Your browser doesn't support javascript.
loading
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.
Derfuss, T; Sastre-Garriga, J; Montalban, X; Rodegher, M; Wuerfel, J; Gaetano, L; Tomic, D; Azmon, A; Wolf, C; Kappos, L.
Afiliación
  • Derfuss T; Neurologic Clinic and Policlinic, University Hospital and University of Basel, Switzerland.
  • Sastre-Garriga J; Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Montalban X; Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Neurology, St Michael's Hospital, University of Toronto, Toronto, Canada.
  • Rodegher M; MS Centre, IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, via Capecelatro, Milan.
  • Gaetano L; Medical Image Analysis Center Basel and Department of Biomedical Engineering, University Hospital, Switzerland.
  • Azmon A; Novartis Pharma AG, Basel, Switzerland.
  • Wolf C; Lycalis, Belgium.
  • Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland.
Mult Scler J Exp Transl Clin ; 6(1): 2055217320907951, 2020.
Article en En | MEDLINE | ID: mdl-32284874

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Mult Scler J Exp Transl Clin Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Mult Scler J Exp Transl Clin Año: 2020 Tipo del documento: Article País de afiliación: Suiza